Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030

Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030 – Regional Analysis -By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Moderate, Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)

Send Enquiry

$2,485$3,885

Description

The Asia Pacific diabetic foot ulcer market was valued at US$ 1,455.82 million in 2022 and is expected to reach US$ 2,472.61 million by 2030; it is estimated to grow at a CAGR of 6.8% from 2022 to 2030.

Surge In Geriatric Population Fuels the Asia Pacific Diabetic Foot Ulcer Market.

Age-associated diabetes is common globally. The deficiency of insulin secretion develops with age and the insulin resistance increases due to a change in body composition and sarcopenia. According to Endocrine Society, an estimated 33% of adults aged 65 or older have diabetes. Additionally, the population is more at risk of developing diabetes-related complications. According to the Global Ageing Survey 2019, the pace of aging (i.e., people aged 60 and above) by 2050 will be nearly a quarter or more in most regions across the world. Older adults are more likely to be diabetic and are further anticipated to develop diabetic foot ulcers and chronic wounds that can severely impact the quality of life. Therefore, with the growing aging population, the demand for advanced diabetic foot ulcer treatments will continue to increase in the coming years.

Asia Pacific Diabetic Foot Ulcer Market Overview

Diabetic foot disease is one of the leading causes of amputation among the population of Asia Pacific. Diabetic foot disease is Australia’s leading cause of amputation and is among the top 20 causes of hospital admissions. As per Diabetic Feet Australia, in 2023, it has been estimated that nearly 300,000 Australians are at risk of developing diabetic foot disease, and 50,000 people live with it. Similarly, according to a study published in 2023 in Wiley Online Library, diabetic foot disease in China is as high as 30% among the diabetic population. Thus, the prevalence of diabetic foot disease in the region will drive the market growth in the upcoming years.

Market players in Asia Pacific are actively developing treatment options for diabetic foot ulcers. For instance, Cannenta, an Australia-based biotechnology company, is engaged in the development of advance wound care therapies for diabetic foot ulcers. In March 2021, Cynata Therapeutics Limited, an Australian clinical-stage stem cell and regenerative medicine company, collaborated with TekCyte Pty Ltd. for the commercial development of Cynata’s mesenchymal stem cells product for diabetic foot ulcers. Therefore, the increasing prevalence of diabetes, rising cases of diabetic foot disease, and initiatives by market players are expected to boost the market growth in Asia Pacific.

Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the Asia Pacific diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held a larger share in 2022.

Based on ulcer type, the Asia Pacific diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held a larger share in 2022.

Based on infection severity, the Asia Pacific diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held a larger share in 2022.

Based on end user, the Asia Pacific diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held a larger share in 2022.

Based on country, the Asia Pacific diabetic foot ulcer market is segmented into China, South Korea, Japan, Australia, India, and the Rest of Asia Pacific. China dominated the Asia Pacific diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, MiMedx Group Inc, and URGO Medical Australia Pty Ltd are some of the leading companies operating in the Asia Pacific diabetic foot ulcer market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

, ,

Year of Publication:

At 6.8% CAGR, the Asia Pacific Diabetic Foot Ulcer Market is speculated to be worth US$ 2,472.61 million by 2030, says The Research Team.

According to The Research Team’ research, the Asia Pacific diabetic foot ulcer market was valued at US$ 1,455.82 in 2022 and is expected to reach US$ 2,472.61 million by 2030, registering a CAGR of 6.8% from 2022 to 2030. Growing research activities to unveil novel wound treatment products is among the critical factors attributed to the Asia Pacific diabetic foot ulcer market expansion.

Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. With the significant growth in the patient pool suffering from chronic wounds, such as diabetic foot ulcers, the need for a systematic treatment approach has accelerated, encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wound management have demonstrated that bioactive wound care products help heal moist wounds more effectively than traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in wound care treatments. For instance, in June 2021, Cynata Therapeutics Limited, an Australian clinical-stage stem cell and regenerative medicine company, signed a license agreement with TekCyte to advance clinical trials in diabetic foot ulcers. The growing research activities and initiative by players will provide lucrative opportunities for the market growth.

On the contrary, high cost of advanced wound care treatments hampers the growth Asia Pacific diabetic foot ulcer market.

Based on treatment type, the Asia Pacific diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held 55.9% share of the Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 814.39 million. It is projected to garner US$ 1,407.87 million by 2030 to expand at 7.1% CAGR during 2022-2030.

Based on ulcer type, the Asia Pacific diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held 52.2% share of the Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 759.71 million. It is projected to garner US$ 1,321.16 million by 2030 to expand at 7.2% CAGR during 2022–2030.
Based on infection severity, the Asia Pacific diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held 48.5% share of Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 706.03 million. It is projected to garner US$ 1,236.98 million by 2030 to expand at 7.3% CAGR during 2022–2030.

Based on end user, the Asia Pacific diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held 56.7% share of Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 825.38 million. It is projected to garner US$ 1,453.59 million by 2030 to expand at 7.3% CAGR during 2022–2030.

Based on country, the Asia Pacific diabetic foot ulcer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China held 36.4% share of Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 530.06 million. It is projected to garner US$ 885.44 million by 2030 to expand at 6.6% CAGR during 2022–2030.

Key players operating in the Asia Pacific diabetic foot ulcer market are Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, MiMedx Group Inc, and URGO Medical Australia Pty Ltd, among others.

In Jan 2023, Convatec announced the launch of ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific diabetic foot ulcer treatment market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific diabetic foot ulcer treatment market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific diabetic foot ulcer treatment market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS


1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Diabetic Foot Ulcer Market Landscape
4.1 Overview
5. Asia Pacific Diabetic Foot Ulcer Market – Key Industry Dynamics
5.1 Market Drivers:
5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:
6. Diabetic Foot Ulcer Market – Asia Pacific Market Analysis
6.1 Asia Pacific Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – by Treatment Type
7.1 Overview
7.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Hydrofiber Dressings
7.3.4.1 Overview
7.3.4.2 Hydrofiber Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.7 Film Dressing
7.3.7.1 Overview
7.3.7.2 Film Dressing: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.8 Other Dressings
7.3.8.1 Overview
7.3.8.2 Other Dressing: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.4 Ultrasound Therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound Therapy: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Ulcer Type
8.1 Overview
8.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Infection Severity
9.1 Overview
9.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
9.3.1 Overview
9.3.2 Mild: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Moderate: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Severe: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By End User
10.1 Overview
10.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
10.5.1 Overview
10.5.2 Home Care: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
11. Diabetic Foot Ulcer Market – Asia Pacific Country Analysis
11.1 Asia Pacific Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Asia Pacific Diabetic Foot Ulcer Market by Country
11.1.1.2 China
11.1.1.2.1 China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 China Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.2.3 China Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.2.3.1 China: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.2.3.2 China: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.2.3.3 China: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.2.4 China Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.2.5 China Diabetic Foot Ulcer Market, by End User
11.1.1.3 Japan
11.1.1.3.1 Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Japan Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.3.3 Japan Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.3.3.1 Japan: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.3.3.2 Japan: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.3.3.3 Japan: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.3.4 Japan Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.3.5 Japan Diabetic Foot Ulcer Market, by End User
11.1.1.4 India
11.1.1.4.1 India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 India Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.4.3 India Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.4.3.1 India: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.4.3.2 India: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.4.3.3 India: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.4.4 India Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.4.5 India Diabetic Foot Ulcer Market, by End User
11.1.1.5 Australia
11.1.1.5.1 Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.2 Australia Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.5.3 Australia Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.5.3.1 Australia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.5.3.2 Australia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.5.3.3 Australia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.5.4 Australia Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.5.5 Australia Diabetic Foot Ulcer Market, by End User
11.1.1.6 South Korea
11.1.1.6.1 South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.2 South Korea Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.6.3 South Korea Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.6.3.1 South Korea: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.6.3.2 South Korea: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.6.3.3 South Korea: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.6.4 South Korea Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.6.5 South Korea Diabetic Foot Ulcer Market, by End User
11.1.1.7 Rest of Asia Pacific
11.1.1.7.1 Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.7.2 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.7.3 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.7.3.1 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.7.3.2 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.7.3.3 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.7.4 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.7.5 Rest of Asia Pacific Diabetic Foot Ulcer Market, by End User
12. Asia Pacific Diabetic Foot Ulcer Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Asia Pacific Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Asia Pacific Diabetic Foot Ulcer Market – Key Company Profiles
13.1 Convatec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast AS
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun SE
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Molnlycke Health Care AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MiMedx Group Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 URGO MEDICAL Australia Pty Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medline Industries LP
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Organogenesis Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Diabetic Foot Ulcer Market Segmentation
Table 2. Asia Pacific Diabetic Foot Ulcer Market, by Country – Revenue and Forecast to 2030 (USD Million)
Table 3. China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 4. China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 5. China: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 6. China: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 7. China: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 8. China Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 9. China Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 10. Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 11. Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 12. Japan: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 13. Japan: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 14. Japan: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 15. Japan Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 16. Japan Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 18. India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 19. India: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 20. India: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 21. India: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 22. India Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 23. India Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 24. Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 25. Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 26. Australia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 27. Australia: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 28. Australia: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 29. Australia Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 30. Australia Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 31. South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 32. South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 33. South Korea: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 34. South Korea: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 35. South Korea: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 36. South Korea Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 37. South Korea Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 38. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 39. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 40. Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 41. Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 42. Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 43. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 44. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 45. Recent Inorganic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 46. Recent Organic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 47. Glossary of Terms, Diabetic Foot Ulcer Market

LIST OF FIGURES

Figure 1. Asia Pacific Diabetic Foot Ulcer Market Segmentation, By Country
Figure 2. Asia Pacific Diabetic Foot Ulcer Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Asia Pacific Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 6. Advanced Wound Care Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Alginate Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Hydrofiber Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Foam Dressings: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Collagen Dressing: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Film Dressing: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Other Dressing: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Biologics: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Growth Factors: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Skin Graft: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Therapy Device: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Negative Pressure Wound Therapy: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ultrasound Therapy: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
Figure 20. Neuropathic Ulcers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Ischemic Ulcers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Neuro-ischemic Ulcers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
Figure 24. Mild: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Moderate: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Severe: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
Figure 28. Hospitals: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Home Care: Asia Pacific Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Asia Pacific Diabetic Foot Ulcer Market, By Country, 2022 ($Mn)
Figure 32. Asia Pacific Diabetic Foot Ulcer Market, By Key Countries, 2022 and 2030 (%)
Figure 33. China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Growth Strategies in the Asia Pacific Diabetic Foot Ulcer Market

The List of Companies – Asia Pacific Diabetic Foot Ulcer Market

1. Convatec Group Plc
2. 3M Co
3. Coloplast AS
4. Smith & Nephew Plc
5. B. Braun SE
6. Medline Industries LP
7. Organogenesis Inc.
8. Mölnlycke Health Care AB
9. MiMedx Group Inc
10. URGO Medical Australia Pty Ltd

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030”